Tiny Phathom Pharmaceuticals Just An Got FDA Blessing And Big-Time Upside: Buy

2025-06-10 10:08:14 ET

Investment Thesis

I've been keeping a close eye on Phathom Pharmaceuticals, Inc. ( PHAT ) for quite some time. I like what they do; their main focus is on gastrointestinal disorders, and they have a pretty promising drug to handle them. "Voquezna," as they call it, is basically Voquezna , which is a potassium-competitive acid blocker. It's this flagship drug that makes me really bullish on the stock. About three days ago, the FDA gave them something called new chemical entity rights on the drug, and whilst I'll explain exactly what this means later, for now, just know that it's somewhat of an exclusivity. Since they got this exclusivity on the 6th of June, the stock has more than doubled, as shown below....

Read the full article on Seeking Alpha

For further details see: